Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production

Journal of Craniofacial Genetics and Developmental Biology

Volumn 18, Issue 3, 1998, Pages 150-158

  Opperman, Lynne A ^a,c   Chhabra, Anikar ^a   Nolen, Amber A ^a   Bao, Yongde ^b   Ogle, Roy C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

Cell proliferation; Cranial sutures; Craniosynostosis; Growth factors; Morphogenesis; Protein synthesis; Tissue interactions

Indexed keywords

COLLAGEN;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DURA MATER; FETUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; COLLAGEN; CRANIAL SUTURES; CRANIOSYNOSTOSES; CULTURE TECHNIQUES; DNA; DURA MATER; FEMALE; MODELS, BIOLOGICAL; PREGNANCY; PROTEIN BIOSYNTHESIS; RATS;

ANIMALIA;

EID: 0031666099     PISSN: 02704145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. BELLUS GA, GAUDENZ K, ZACKAI EH, CLARKE LA, SZABO J, FRANCOMANO CA, MUENKE M: Identical mutations in three different growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet 14:174-176, 1996.
2. BIDLINGMEYER BA, COHEN SA, TARVIN TL: Rapid analysis of amino acids using pre-column derivitization. J Chromatogr 336:93-104, 1984.
3. BRADLEY JP, LEVINE JP, BLEWETT C, KRUMMEL T, MCCARTHY JG, LONGAKER MT: Studies in cranial suture biology: In vitro cranial suture fusion. Cleft Palate-Craniofac J 33:150-156, 1996.
4. BRESNICK SD, SCHENDEL S: Growth factors in human craniosynostosis. 63rd Annual Scientific Meeting, ASPRS-PSEF-ASMS, San Diego, CA, pp. 41-42, Sept. 1994.
5. BURGESS WH, MACIAG T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606, 1989.
6. CARTER DH, SLOAN P, AARON JE: Immunolocalization of collagen types I and III, tenascin and fibronectin in intramembranous bone. J Histochem Cytochem 39:599-606, 1991.
7. CHEN TL, BATES RL: Recombinant human transforming growth factor β1 modulates bone remodeling in a mineralizing bone organ culture. J Bone Min Res 8:423-427, 1993.
8. COE MR, SUMMERS TA, PARSONS SJ, BOSKEY AL, BALIAN G: Matrix mineralization in hypertrophic chondrocyte cultures. Bone Min 18:91-106, 1992.
9. COHEN MM JR: Sutural biology and the correlates of craniosynostosis. Am J Med Genet 47:581-616, 1993.
10. COLVIN JS, BOHNE BA, HARDING GW, MCEWEN DG, ORNITZ DM: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet 12:390-397, 1996.
11. D'AMORE P: Modes of FGF release in vivo and in vitro. Cancer Met Rev 9:227-238, 1990.
12. DENG C, WYNSHAW-BORIS A, ZHOU F, KUO A, LEDER P: Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921, 1996.
13. DEPOLLACK C, RENIER D, HOTT M, MARIE PJ: Increased bone formation and osteoblastic cell phenotype in premature cranial suture ossification (craniosynostosis). J Bone Min Res 11:401-407, 1996.
14. DUNLOP L-LT, HALL BK: Relationships between cellular condensation, pre-osteoblast formation and epithelial-mesenchymal interactions in initiation of osteogenesis. Int J Dev Biol 39:357-371, 1995.
15. FRENKEL SR, HERSKOVITS MS, SINGH IJ: Fibroblast growth factor: Effect on osteogenesis and chondrogenesis in the chick embryo. Acta Anat 145:265-268, 1992.
16. GOLDIN GV, OPPERMAN LA: Induction of supernumerary tracheal buds and the stimulation of DNA synthesis in the embryonic chick lung and trachea by epidermal growth factor. J Embryol Exp Morphol 60:235-243, 1980.
17. GRANT WT, SUSSMAN MD, BALIAN G: A disulfide-bonded short chain collagen synthesized by degenerative and calcifying zones of bovine growth plate cartilage. J Biol Chem 260:3798-3803, 1985.
18. HARRIS SE, BONEWALD LF, HARRIS MA, SABATINI M, DALLAS S, FENG JQ, GHOSH-CHOUDHURY N, WOZNEY J, MUNDY GR: Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase and type I collagen mRNA in long term cultures of fetal rat calvarial osteoblasts. J Bone Min Res 9:855-863, 1994.
19. IZUMI T, SCULLY SP, HEYDEMANN A, BOLANDER ME: Transforming growth factor β1 stimulates type II collagen expression in cultured periosteum-derived cells. J Bone Min Res 7:115-121, 1992.
20. JABS EW, MULLER U, LI X, MA L, LUO W, HAWORTH IS, KLISAK I, SPARKES R, WARMAN ML, MULLIKEN JB, SNEAD ML, MAXSON RE: A mutation in the homeodomain of the human Msx2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75:443-450, 1993.
21. JABS EW, LI X, SCOTT AF, MEYERS G, CHEN W, ECCLES M, MAO J-I, CHARNAS LR, JACKSON CE, JAYE M: Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast receptor 2. Nature Genet 8:275-279, 1994.
22. KOKICH VG: The biology of sutures. In: Cohen MM (ed) Craniosynostosis: Diagnosis, evaluation and management. New York: Raven Press, pp. 81-103, 1986.
23. LAJEUNIE E, LE MERRER M, BONAÏTI-PELLIE C, MARCHAC D, RENIER D: A genetic study of non-syndromic coronal craniosynostosis. Am J Med Genet 55:500-504, 1995.
24. LIN KY, NOLEN AA, JANE, JA, GAMPPER TJ, OPPERMAN LA, OGLE RC: Elevated levels of transforming growth factor beta (TGF)-β2&3 in lambdoid sutures from children with persistent plagiocephaly. Cleft Palate-Craniofac J 34:331-337, 1997.
25. LIU YH, KUNDU R, WU L, LUO W, IGNELZI MA JR, SNEAD ML, MAXSON RE JR: Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci USA 92:6137-6141, 1995.
26. LIU YH, MA L, KUNDU R, IGNELZI MA JR, SANGIORGI F, WU L, LUO W, SNEAD ML, MAXSON RE JR: Function of the Msx2 gene in the morphogenesis of the skull. Ann NY Acad Sci 785:48-58, 1996.
27. MCCAFFREY TA, FALCONE DJ, DU B: Transforming growth factor-β1 is a heparin-binding protein: Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1. J Cell Physiol 152:430-440, 1992.
28. Moss ML: Inhibition and stimulation of sutural fusion in the rat calvaria. Anat Rec 136:457-467, 1960.
29. MUENKE M, GRIPP KW, MCDONALD-MCGINN DM, GAUDENZ K, WHITAKER LA, BARTLETT SP, MARKOWITZ RI, ROBIN NH, NWOKORO N, MULVIHILL JJ, LOSKEN HW, MULLIKEN JB, GUTTMACHER AE, WILROY RS, CLARKE LA, HOLLWAY G, ADES LC, HAAN EA, MULLEY JC, COHEN MM JR, BELLUS GA, FRANCOMANO CA, MOLONEY DM, WALL SA, WILKIE AO: A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60:555-564, 1997.
30. MUENKE M, SCHELL U, HEHR A, ROBIN NH, LOSKEN HW, SCHINZEL A, PULLEYN LJ, RUTLAND P, REARDON W, MALCOLM S, WINTER RM: A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 8:269-274, 1994.
31. NISWANDER L, MARTIN GR: FGF-4 and BMP-2 have opposite effects on limb growth. Nature 361:68-71, 1993.
32. OPPERMAN LA, BROOKE BS, CHHABRA A, NOLEN AA, OGLE RC: Expression of transforming growth factor (TGF)-β1, 2 & 3 by dura mater: Role in regulating cranial suture morphogenesis. Molec Biol Cell 6:208a, 1995a.
33. OPPERMAN LA, NOLEN AA, OGLE RC: TGF-β1, TGF-β2 and TGF-β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Min Res 12:301-310, 1997.
34. OPPERMAN LA, PASSARELLI RW, MORGAN EP, REINTJES M, OGLE RC: Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Min Res 10:1978-1987, 1995b.
35. OPPERMAN LA, PASSARELLI RW, NOLEN AA, GAMPPER TJ, LIN KL OGLE RC: Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol 32:627-632, 1996.
36. OPPERMAN LA, SWEENEY TM, REDMON J, PERSING JA, OGLE RC: Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dynam 198:312-322, 1993.
37. PARALKAR VM, VUKICEVIC S, REDDI H: Transforming growth factor beta type one binds collagen type IV of basement membrane matrix: Implications for development. Dev Biol 143:303-308, 1991.
38. PERSING JA, BABLER WF, WINN HR, JANE JA, RODEHEAVER GT: Age as a critical factor in the success of surgical correction of craniosynostosis. J Neurosurg 54:601-606, 1981.
39. REARDON W, WINTER RM, RUTLAND P, PULLEYN LJ, JONES BM, MALCOLM S: Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet 8:98-103, 1994.
40. ROTH DA, BRADLEY JP, LEVINE JP, MCMULLEN HF, MCCARTHY JG, LONGAKER MT: Studies in cranial suture biology. Part II. Role of the dura in cranial suture fusion. Plast Reconstruct Surg 97:693-699, 1996.
41. ROTH DA, LONGAKER MT, BREITBART AS, MCCARTHY JG, GOLD LI: The role of transforming growth factor beta-1 in rat cranial suture fusion. 63rd Annual Scientific Meeting ASPRS-PSEF-ASMS, San Diego, California, pp. 39-40, September 1994.
42. ROTH DA, LONGAKER MT, MCCARTHY JG, HAN VK, GOLD LI: The analysis of TGF-β1, TGF-β2, TGF-β3 and IGF-1 in premature cranial suture fusion in humans. Annual Meeting of the Cleft Palate-Craniofacial Association, Tampa, FL, p. 30, April 26-30, 1995.
43. RUTLAND P, PULLEYN LJ, REARDON W, BARAITSER M, HAYWARD R, JONES B, MALCOLM S, WINTER RM, OLDRIDGE M, SLANEY SF, POOLE MD, WILKIE AOM: Identical mutations in the FGFR2 gene causes both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet 9:173-176, 1995.
44. SHIANG R, THOMPSON LM, ZHU Y-Z, CHURCH DM, FIELDER TJ, BOCIAN M, WINOKUR ST, WASMUTH JJ: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarf ism, achondroplasia. Cell 78:335-342, 1994.
45. SMITH DW, TONDURY G: Origin of the calvaria and its sutures. Am J Dis Child 132:662-666, 1978.
46. SOOD S, ELDADAH ZA, KRAUSE WL, MCINTOSH I, DIETZ HC: Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nature Genet 12:209-211, 1996.
47. THOMAS JT, LIN K, NANDEDKAR M, CAMARGO M, CERVENKA J, LUYTEN FP: A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nature Genet 12:315-317, 1996.
48. WILKIE AOM, SLANEY SF, OLDRIDGE M, POOLE MD, ASHWORTH GJ, HOCKLEY AD, HAYWARD RD, DAVID DJ, PULLEYN LJ, RUTLAND P, MALCOLM S, WINTER RM, REARDON W: Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 9:165-172, 1995.
49. YEN EHK, YUE CS, SUGA DM: The effect of sutural growth rate on collagen phenotype synthesis. J Dent Res 68:1058-1063, 1989a.
50. YEN EHK, YUE CS, SUGA DM: Effect of force level on synthesis of type III and type I collagen in mouse interparietal suture. J Dent Res 68:1746-1751, 1989b.